Bartlomiej Pawlik

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

mTOR Modulation Affects Galectin-1 Expression in KMT2A-rearranged Acute Lymphoblastic Leukemia Cells.

mTOR Modulation Affects Galectin-1 Expression in KMT2A-rearranged Acute Lymphoblastic Leukemia Cells.

Journal: Anticancer research

Published: September 19, 2025

Single-cell profiling of CD19-directed CAR T-cell phenotypes and immune system dynamics in pediatric B-cell acute lymphoblastic leukemia.

Single-cell profiling of CD19-directed CAR T-cell phenotypes and immune system dynamics in pediatric B-cell acute lymphoblastic leukemia.

Journal: Haematologica

Published: June 06, 2025

Single-cell profiling of CAR-T CD19 cell phenotypes and immune system dynamics in pediatric BCP-ALL.

Single-cell profiling of CAR-T CD19 cell phenotypes and immune system dynamics in pediatric BCP-ALL.

Journal: bioRxiv : the preprint server for biology

Published: April 16, 2025

CD19-CAR T-cell therapy with sorafenib in post-HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch-A case report and review of the literature.

CD19-CAR T-cell therapy with sorafenib in post-HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch-A case report and review of the literature.

Journal: British journal of haematology

Published: March 08, 2024

Proteomic and Transcriptomic Landscapes of Alström and Bardet-Biedl Syndromes.

Proteomic and Transcriptomic Landscapes of Alström and Bardet-Biedl Syndromes.

Journal: Genes

Published: October 30, 2022

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor.

MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor.

Journal: International journal of molecular sciences

Published: October 22, 2022

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile.

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile.

Journal: Journal of clinical medicine

Published: May 21, 2022

Multiomic analysis on human cell model of wolfram syndrome reveals changes in mitochondrial morphology and function.

Multiomic analysis on human cell model of wolfram syndrome reveals changes in mitochondrial morphology and function.

Journal: Cell communication and signaling : CCS

Published: July 06, 2021

New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration.

New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration.

Journal: International journal of molecular sciences

Published: May 18, 2021

Neutrophil Elastase Defects in Congenital Neutropenia.

Neutrophil Elastase Defects in Congenital Neutropenia.

Journal: Frontiers in immunology

Published: January 15, 2021

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging.

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging.

Journal: Nature chemical biology

Published: June 03, 2020

Gene expression of ASNS, LGMN and CTSB is elevated in a subgroup of childhood BCP-ALL with PAX5 deletion.

Gene expression of ASNS, LGMN and CTSB is elevated in a subgroup of childhood BCP-ALL with PAX5 deletion.

Journal: Oncology letters

Published: April 20, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026